Cargando…

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Detalles Bibliográficos
Autores principales:	Campuzano-Zuluaga, Germán, Pimentel, Agustin, Chapman-Fredricks, Jennifer R, Ramos, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042442/ http://dx.doi.org/10.1186/1742-4690-11-S1-P129

Ejemplares similares

Clinical features and outcome of adult T-cell leukemia/lymphoma: University of Miami experience
por: Pimentel, Agustin, et al.
Publicado: (2014)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients
por: Pornkuna, Ratiorn, et al.
Publicado: (2014)

Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma
por: Toomey, Ngoc, et al.
Publicado: (2015)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)

Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012)

Differential HLA-dependent HIV evolution among subtypes
por: Dilernia, DA, et al.
Publicado: (2006)

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
por: Phillips, Adrienne, et al.
Publicado: (2015)

Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011)

Leukemia/lymphoma development in IL-15-deficient TCR-transgenic mice
por: Dubois, Sigrid, et al.
Publicado: (2015)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1
por: Melo, Omar, et al.
Publicado: (2015)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
por: Utsunomiya, Atae, et al.
Publicado: (2015)

P496: PHENOTYPIC SUBTYPES OF LEUKEMIC TRANSFORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2023)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)
por: Merle, Harold, et al.
Publicado: (2015)

Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
por: Sibon, David, et al.
Publicado: (2015)

Validation and clinical correlation of triplex CD3, CD8 and FOXP3 IHC of tumor-infiltrating lymphocytes in follicular lymphoma
por: Mansfield, James, et al.
Publicado: (2014)

Cooperation between the human T-cell leukemia virus type-1 p30(II) protein and host cellular factors during oncogenic transformation and retroviral carcinogenesis
por: Romeo, Megan, et al.
Publicado: (2014)

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study
por: Foca, A, et al.
Publicado: (2014)

Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
por: Hilgeroth, Andreas, et al.
Publicado: (2014)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

An efficient vaccine against bovine leukemia virus
por: Gutiérrez, Gerónimo, et al.
Publicado: (2015)

Epigenetic regulation of CD1d-mediated antigen presentation in B cell lymphoma
por: Tiper, Irina, et al.
Publicado: (2014)

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas
por: Marie-Cardine, Anne, et al.
Publicado: (2013)

30. The paradox
por: Saleh, Mohammed, et al.
Publicado: (2019)

Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions
por: Oka, Takashi, et al.
Publicado: (2014)

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015)

The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2014)

The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2014)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

Comparative expressed sequence hybridisation revealed distinct chromosomal regions of differential gene expression in breast cancer subtypes
por: Vanden Bempt, I, et al.
Publicado: (2005)

Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model
por: Nakamura, M, et al.
Publicado: (2008)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: retrospective study in Martinique
por: Baubion, Emilie, et al.
Publicado: (2015)

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)

Immunogenicity of native and CD4 liganded monomeric and trimeric envelope glycoproteins based on HIV-1 Subtype C consensus Founder virus sequences
por: Killick, MA, et al.
Publicado: (2012)

Molecular epidemiology of HIV-1 subtype B in the Basque Country (Spain)
por: Patiño, Juan Angel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kmqg2lcebj3mcoboainfrfqiet